Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria
Open Access
- 21 October 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (16) , 2950-2959
Abstract
Inhibition of cyclooxygenase (COX)–derived prostaglandins (PGs) by nonsteroidal anti-inflammatory drugs (NSAIDs) mediates leukocyte killing of bacteria. However, the relative contribution of COX1 versus COX2 to this process, as well as the mechanisms controlling it in mouse and humans, are unknown. Indeed, the potential of NSAIDs to facilitate leukocyte killing of drug-resistant bacteria warrants investigation. Therefore, we carried out a series of experiments in mice and humans, finding that COX1 is the predominant isoform active in PG synthesis during infection and that its prophylactic or therapeutic inhibition primes leukocytes to kill bacteria by increasing phagocytic uptake and reactive oxygen intermediate-mediated killing in a cyclic adenosine monophosphate (cAMP)-dependent manner. Moreover, NSAIDs enhance bacterial killing in humans, exerting an additive effect when used in combination with antibiotics. Finally, NSAIDs, through the inhibition of COX prime the innate immune system to mediate bacterial clearance of penicillin-resistant Streptococcus pneumoniae serotype 19A, a well-recognized vaccine escape serotype of particular concern given its increasing prevalence and multi-antibiotic resistance. Therefore, these data underline the importance of lipid mediators in host responses to in-fection and the potential of inhibitors of PG signaling pathways as adjunc-tive therapies, particularly in the con-text of antibiotic resistance.Keywords
This publication has 50 references indexed in Scilit:
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisNature, 2009
- A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shockCritical Care, 2009
- The dual role of bacteriocins as anti- and probioticsApplied Microbiology and Biotechnology, 2008
- Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMPBlood, 2008
- Cyclic AMPAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Impaired Opsonization with C3b and Phagocytosis ofStreptococcus pneumoniaein Sera from Subjects with Defects in the Classical Complement PathwayInfection and Immunity, 2008
- An antiinflammatory role for IKKβ through the inhibition of “classical” macrophage activationJournal of Experimental Medicine, 2008
- An Unbiased Systems Genetics Approach to Mapping Genetic Loci Modulating Susceptibility to Severe Streptococcal SepsisPLOS Pathogens, 2008
- Hematopoietic prostaglandin D2synthase controls the onset and resolution of acute inflammation through PGD2and 15-deoxyΔ12–14PGJ2Proceedings of the National Academy of Sciences, 2007
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988